NP93420 Rituximab Subcut

A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Supply)
Duration
not specified
Value
£2M
Sector
HEALTH
Published
01 May 2024
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

Supply of Rituximab Subcut (Mabthera®) to NHS Scotland.

Total Quantity or Scope

The Framework Agreement is for the supply of Rituximab Subcut to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

Award Detail

1 Roche Products (Welwyn Garden City)
  • Value: £1,993,338

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

The estimated value of the Framework Agreement referred to in Section V.2.4 covers the nine (9) month duration of the proposed modification period of the Framework Agreement. NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=765324. (SC Ref:765324)

Reference

Domains